Jiao, Pengfei <br/><br/>
SNHG14 silencing suppresses the progression and promotes cisplatin sensitivity in non-small cell lung cancer.  [electronic resource] 

 -  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie  Sep 2019 
 - 109164 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1950-6007 
<br/><br/><label>Standard No.: </label>10.1016/j.biopha.2019.109164  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Base Sequence<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Cisplatin--pharmacology<br/>Disease Progression<br/>Drug Resistance, Neoplasm--drug effects<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Gene Silencing<br/>HMGB1 Protein--metabolism<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>MicroRNAs--metabolism<br/>Neoplasm Invasiveness<br/>RNA, Long Noncoding--genetics<br/>Up-Regulation--drug effects